Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Prostate Cancer and Prostatic Diseases|February 28, 2024
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient OutcomesNicholas A Zorko, Allison Makovec, Andrew Elliott, et al.
Cancer Research Communications|December 18, 2023
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United StatesEmily M Rencsok, Natalie Slopen, Hannah D McManus, et al.
Clinical Genitourinary Cancer|January 11, 2025
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial CarcinomaRafee Talukder, Dimitra Rafailia Bakaloudi, Dimitrios Makrakis, et al.
The Journal of Urology|January 24, 2020
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective StudyNatalie J Miller, Ali Raza Khaki, Leonidas N Diamantopoulos, et al.
Cancer|December 13, 2019
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitorsAli Raza Khaki, Ang Li, Leonidas N Diamantopoulos, et al.
European Urology Oncology|December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerJacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Prostate Cancer and Prostatic Diseases|August 7, 2021
PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancerVadim S Koshkin, Vaibhav G Patel, Alicia Ali, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
Clinical Genitourinary Cancer|September 6, 2024
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint InhibitorDimitra Rafailia Bakaloudi, Rafee Talukder, Dimitrios Makrakis, et al.
Clinical Genitourinary Cancer|May 16, 2025
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology SubtypesDimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, et al.
Pageof 11